SCL — Stepan Company

Summary of Stepan Company Q1 2026 Earnings Call

1. Key Financial Results and Metrics

• Net Loss: Reported a net loss of $41.4 million ($1.81 per diluted share), compared to a net income of $19.7 million ($0.86 per diluted share) in Q1 2025.
• Adjusted Net Income: $10.3 million ($0.45 per diluted share), down 47% from $19.3 million ($0.84 per diluted share) year-over-year.
• Adjusted EBITDA: $49.6 million, a 14% decline from $57.5 million in the prior year.
• Cash from Operations: $17 million; Free Cash Flow was negative $14 million due to higher working capital requirements.
• Dividends: Paid $8.9 million in dividends, with a declared quarterly cash dividend of $0.395 per share.
• Net Debt: $511 million, with a leverage ratio of 2.7x, improved from Q1 2025.

2. Strategic Updates and Business Highlights

• Sales Growth: Organic net sales increased by 4% year-over-year, driven by strong performance in Crop Productivity, Oilfield, and Industrial Cleaning segments, despite flat organic volume overall.
• Project Catalyst: Progressing on schedule, expected to deliver approximately $100 million in pretax savings over two years, with 60% of savings anticipated in 2026.
• Operational Excellence: Continued focus on safety and operational efficiency, achieving the strongest safety performance on record in Q1 2026.
• Product Performance: Specialty Products saw a 30% volume growth, while Polymers adjusted EBITDA grew by 8% due to North American volume growth.

3. Forward Guidance and Outlook

• Market Position: Confident in the ability to grow in strategic markets despite macroeconomic challenges, with expectations for improved performance in Surfactants and Polymers as production issues resolve.
• Q2 Expectations: Anticipated recovery in Surfactant EBITDA, with a significant portion of Project Catalyst savings expected to materialize in Q2.
• Long-term Strategy: Focus on customer-centric innovation, diversification into higher-value markets, and disciplined capital allocation.

4. Bad News, Challenges, or Points of Concern

• Restructuring Charges: Included a $65.4 million pretax restructuring charge related to site closures, impacting net income significantly.
• Surfactant Business Pressures: Experienced lower absorption and production timing issues, particularly in Asia, competitive pressures in Mexico, and elevated oleochemical input costs.
• Negative Cash Flow: Free cash flow was negative, reflecting typical first-quarter working capital build.
• Geopolitical Risks: Ongoing conflicts, such as the Iran war, are impacting raw material costs and availability, although the company has managed to pass through some price increases.

5. Notable Q&A Insights

• Raw Material Impact: The company is experiencing raw material inflation due to geopolitical tensions but has successfully implemented price increases to mitigate impacts.
• Demand Trends: Despite some trade-down behavior among consumers, demand remains resilient, particularly in Tier 2 and Tier 3 customer segments.
• Surfactants Outlook: Management expects recovery in Surfactant margins as temporary production issues resolve and pricing stabilizes.
• Oilfield Business Growth: The Oilfield segment is positioned for growth, focusing on maximizing productivity from existing wells rather than increasing drilling activity.
• CapEx Focus: Majority of capital expenditures are directed towards maintaining operational reliability, with a small portion allocated for growth initiatives.

This summary encapsulates the key points from Stepan Company's Q1 2026 earnings call, highlighting financial performance, strategic initiatives, and market outlook while addressing challenges faced by the company.